Application of CDK4/6 inhibition therapies to PDACs

被引：0
|
作者：
Zhang, Yuanyuan [1 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Oncol & Mol Biol, Kanazawa, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3215
引用
收藏
页码：1937 / 1937
页数：1
相关论文
共 50 条
  • [41] Investigating CDK4/6 inhibition in triple negative breast cancer
    Guo, Qiuchen
    Goreczny, Gregory J.
    Spasic, Milos
    Maynard, Adam
    McAllister, Sandra S.
    CANCER RESEARCH, 2021, 81 (04)
  • [42] Novel mechanisms of acquired resistance to selective CDK4/6 inhibition
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2018, 78 (13)
  • [43] CDK4/6 inhibition triggers anti-tumour immunity
    Goel, Shom
    DeCristo, Molly J.
    Watt, April C.
    BrinJones, Haley
    Sceneay, Jaclyn
    Li, Ben B.
    Khan, Naveed
    Ubellacker, Jessalyn M.
    Xie, Shaozhen
    Metzger-Filho, Otto
    Hoog, Jeremy
    Ellis, Matthew J.
    Ma, Cynthia X.
    Ramm, Susanne
    Krop, Ian E.
    Winer, Eric P.
    Roberts, Thomas M.
    Kim, Hye-Jung
    McAllister, Sandra S.
    Zhao, Jean J.
    NATURE, 2017, 548 (7668) : 471 - +
  • [44] CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?
    Sakach, Elizabeth
    Keskinkilic, Merve
    Wood, Sarah
    Canning, Madison
    Kalinsky, Kevin
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1103 - 1119
  • [45] CDK4/6 INHIBITION FOR THE TREATMENT OF ATYPICAL TERATOID/RHABDOID TUMORS
    Aoki, Yasuyuki
    Banerjee, Anuradha
    Phillips, Joanna
    Prados, Michael
    Gupta, Nalin
    James, David
    Rintaro, Hashizume
    NEURO-ONCOLOGY, 2011, 13 : I12 - I12
  • [46] Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is Everything
    Fassl, Anne
    Sicinski, Piotr
    CANCER CELL, 2020, 37 (03) : 265 - 267
  • [47] Development and characterization of a novel CDK4/6 inhibitor for the treatment of CDK4/6 dependent cancers
    O'Brien, Neil A.
    McDermott, Martina S.
    O'Boyle, Brendan M.
    Hilf, Justin A.
    Loson, Oliver
    Chau, Kevin
    Jia, Weiping
    Kamranpour, Naeimeh
    Luo, Tong
    Ayala, Raul
    Issakhanian, Shawnt
    Glaspy, John A.
    Stoltz, Brian M.
    Slamon, Dennis J.
    CANCER RESEARCH, 2023, 83 (07)
  • [48] Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
    Raub, Thomas J.
    Wishart, Graham N.
    Kulanthaivel, Palaniappan
    Staton, Brian A.
    Ajamie, Rose T.
    Sawada, Geri A.
    Gelbert, Lawrence M.
    Shannon, Harlan E.
    Sanchez-Martinez, Concepcion
    De Dios, Alfonso
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (09) : 1360 - 1371
  • [49] Combined inhibition of CDK2 and CDK4/6 overcomes acquired resistance to CDK4/6 inhibitors in breast cancer via RB-independent pathway
    Pandey, Kamal
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Targeting CDK4 and CDK6 in cancer
    Shom Goel
    Johann S. Bergholz
    Jean J. Zhao
    Nature Reviews Cancer, 2022, 22 : 356 - 372
12345